Ken Griffin’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
Other funds holding COGT
Ken Griffin's COGT Position: Q3 2026 in Review
Ken Griffin increased its Cogent Biosciences (COGT) stake by 17% in Q3 2026, buying an estimated $5.18M and bringing the position to 990,010 shares worth $31.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2028.
Ken Griffin first reported a position in COGT in Q1 2018 and has held it in 28 quarters since. The position peaked at $66M in Q1 2026. 316 funds tracked by Wall St. Rank hold COGT as of Q3 2026.
- Ken Griffin held 990,010 shares of Cogent Biosciences worth $31.7M as of Q3 2026.
- Ken Griffin bought 140,316 Cogent Biosciences shares in Q3 2026, an estimated $5.18M.
- Cogent Biosciences made up ﹤0.01% of Ken Griffin's portfolio in Q3 2026, its #2028 holding.
- Ken Griffin first reported a position in Cogent Biosciences in Q1 2018 and has held it in 28 quarters since.
- Ken Griffin's Cogent Biosciences position peaked at $66M in Q1 2026.
- 316 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.